A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature
DOI 10.1038/243290a0

Cited by (1,005)

Items 601–700 of 1,005

  1. STI571: A Paradigm of New Agents for Cancer Therapeutics
    Michael J. Mauro, Michael E O'Dwyer, Michael Charles Heinrich, Brian J. Druker · 2002 · Journal of Clinical Oncology
  2. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia
    Elena L. Prigogina, Elena W. Fleischman, М. А. Волкова, M A Frenkel · 1978 · Human Genetics
  3. Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia
    Stephen Mackinnon, Jill Hows, John M. Goldman · 1990 · Blood
  4. THE PATHOGENESIS OF MYELOPROLIFERATIVE SYNDROMES
    John W. Adamson, Philip J. Fialkow · 1978 · British Journal of Haematology
  5. The Bone Marrow Microenvironment as Niche Retreats for Hematopoietic and Leukemic Stem Cells
    Felix Nwajei, Marina Y Konopleva · 2013 · Advances in Hematology
  6. Effect of Mutational Inactivation of Tyrosine Kinase Activity on BCR/ABL-Induced Abnormalities in Cell Growth and Adhesion in Human Hematopoietic Progenitors
    Pandurangan Ramaraj, Harjeet Singh, Ning Niu, Su Chu, Melissa S. Holtz, Jiing Kuan Yee, Ravi Bhatia · 2004 · Cancer Research
  7. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines
    Debasmita Roy, Sang‐Hoon Sin, Blossom Damania, Dirk P. Dittmer · 2011 · Blood
  8. Survival implications of molecular heterogeneity in variant Philadelphia‐positive chronic myeloid leukaemia
    Alistair G. Reid, Brian J.P. Huntly, Colin D. Grace, Anthony Richard Green, Elisabeth P. Nacheva · 2003 · British Journal of Haematology
  9. The colony stimulating factors discovery, development, and clinical applications
    Donald Metcalf · 1990 · Cancer
  10. Evidence that the phl Gene Encodes a 160,000-Dalton Phosphoprotein with Associated Kinase Activity
    K Stam, Nora Heisterkamp, Fred H. Reynolds, John Groffen · 1987 · Molecular and Cellular Biology
  11. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia
    Chi Xu, Hanjiang Fu, Li Gao, Lili Wang, W Wang, J Li, Y Li, Liping Dou, Xuefeng Gao, X Luo et al. · 2012 · Oncogene
  12. Targeting chromatin complexes in fusion protein-driven malignancies
    Gerard L. Brien, K. Stegmaier, S. Armstrong · 2019 · Nature Reviews. Cancer
  13. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers
    Qing Zhang, Wenwen Chen, Xue Sun, Die Qian, Dan Dan Tang, Li Lin Zhang, Mei Yan Li, Lin Yu Wang, Chunjie Wu, Wei Peng · 2022 · International Journal of Biological Sciences
  14. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
    Aleksandra Rizo, Sarah J. Horton, Sandra G. M. Olthof, Bert Dontje, Albertina Ausema, Ronald P. van Os, Vincent van den Boom, Edo Vellenga, Gerald de Haan, Jan Jacob Schuringa · 2010 · Blood
  15. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
    for the SAKK and the German CML Study Group, Alice Charlotte Fabarius, Lida Kalmanti, Christian Dietz, Michael Lauseker, Sebastien Ly Rinaldetti, Claudia Haferlach, Gudrun Göhring, Brigitte Schlegelberger, Martine Jotterand et al. · 2015 · Annals of Hematology
  16. Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell‐Associated Disorders
    Tim H. Brümmendorf, Nathalie Rufer, Tessa L. Holyoake, JAREK MACIEJEWSKI, MICHAEL J. BARNETT, Connie J. Eaves, Allen C. Eaves, Neal S. Young, Peter M. Lansdorp · 2001 · Annals of the New York Academy of Sciences
  17. Growth Factor Stimulation Reduces Residual Quiescent Chronic Myelogenous Leukemia Progenitors Remaining after Imatinib Treatment
    Melissa S. Holtz, Stephen J. Forman, Ravi Bhatia · 2007 · Cancer Research
  18. Gene-amplification model of carcinogenesis.
    Martin L. Pall · 1981 · Proceedings of the National Academy of Sciences
  19. Molecular mechanisms of oncogenesis.
    Thomas A. Seemayer, Webster K. Cavenee · 1989 · PubMed
  20. Contemporary pre-clinical development of anticancer agents – What are the optimal preclinical models?
    Giovanna L.M. Damia, Maurizio D’Incalci · 2009 · European Journal of Cancer
  21. Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines
    Fabrizio Manetti, Chiara Brullo, Matteo Magnani, Francesca Mosci, Beatrice Chelli, Emmanuele Crespan, Silvia Schenone, Antonella Naldini, Olga Bruno, Maria Letizia Trincavelli et al. · 2008 · Journal of Medicinal Chemistry
  22. BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry
    Ashley Hamilton, Lucy J. Elrick, Svetlana Myssina, Mhairi Copland, Heather G. Jørgensen, Junia V. Melo, Tessa L. Holyoake · 2006 · Leukemia
  23. Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP
    Nicoletta Testoni, Giulia Marzocchi, Simona Luatti, Marilina Amabile, Carmen Baldazzi, Monica Stacchini, Mauro Nanni, Giovanna Rege‐Cambrin, Emilia Giugliano, Ursula Giussani et al. · 2009 · Blood
  24. Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growth and Apoptosis
    Alessandra Di Bacco, Karen Keeshan, Sharon L. McKenna, Thomas G. Cotter · 2000 · The Oncologist
  25. Considerations for Targeting Malignant Stem Cells in Leukemia
    Mónica L. Guzmán, Craig T. Jordan · 2004 · Cancer Control
  26. Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations
    Evelin Schröck, Hesed M. Padilla‐Nash · 2000 · Seminars in Hematology
  27. Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia
    Galina Yoffe, Mark B. Blick, Hagop M. Kantarjian, Gary Spitzer, Jordan U. Gutterman, Moshe Talpaz · 1987 · Blood
  28. Frequent and extensive deletion during the 9,22 translocation in CML
    DW Popenoe, K E Schaefer-Rego, JG Mears, A Bank, David S. Leibowitz · 1986 · Blood
  29. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
    Frank Szulzewsky, Sonali Arora, Pia Hoellerbauer, Claire King, Erica Nathan, Marina Chan, Patrick Joseph Cimino, Tatsuya Ozawa, Daisuke Kawauchi, Kristian W. Pajtler et al. · 2020 · Genes & Development
  30. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study
    Mônika Conchon, Sabri Saeed Sanabani, Israel Bendit, Fernanda Maria Santos, Mariana Gomes Serpa, Pedro Enrique Dorliac-Llacer · 2009 · Journal of Hematology & Oncology
  31. Chromosomal translocation t(14;18) in healthy individuals
    Frank Schüler, Carsten Hirt, Gottfried Dölken · 2003 · Seminars in Cancer Biology
  32. The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
    Franck Emmanuel Nicolini, A. R. Ibrahim, Simona Soverini, Giovanni Martinelli, Martin C. Müller, Andreas Hochhaus, Inge Høgh Dufva, D.-W. Kim, Jörge E. Cortes, Michael J. Mauro et al. · 2013 · Haematologica
  33. New agents in cancer clinical trials
    Julian Adams, Peter J. Elliott · 2000 · Oncogene
  34. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy
    MS Lee, Hagop M. Kantarjian, Moshe Talpaz, EJ Freireich, AB Deisseroth, J Trujillo, Sanford A. Stass · 1992 · Blood
  35. Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCRexpression, elevated BCR-ABL levels, or karyotypic instability
    Brian J.P. Huntly, Anthony J. Bench, Éric Delabesse, Alistair G. Reid, Juan Li, Mike A. Scott, Lynda J. Campbell, Jenny Byrne, Eleanor M. Pinto, A. Brizard et al. · 2002 · Blood
  36. Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction
    Alexander Dobrovic, KJ Trainor, AA Morley · 1988 · Blood
  37. In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib
    Manuel A. Sobrinho-Simões, Vicki J. Wilczek, J Score, Nicholas C.P. Cross, Jane F. Apperley, Junia V. Melo · 2010 · Blood
  38. A BCR-ABLp190 Fusion Gene Made by Homologous Recombination Causes B-Cell Acute Lymphoblastic Leukemias in Chimeric Mice With Independence of the Endogenous bcr Product
    Andrés Castellanos‐Martín, Belén Pintado, Eduardo Weruaga, R. Arévalo, A. López, A. Orfao, Isidro Sánchez-Garcı́a · 1997 · Blood
  39. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice
    H Honda, Takeshi Fujii, Masaaki Takatoku, Hiroyuki Mano, Owen N. Witte, Y Yazaki, Hisamaru Hirai · 1995 · Blood
  40. Intraosseous well-differentiated osteosarcoma
    K. Krishnan Unni, David C. Dahlin, Richard A. McLeod, Douglas J. Pritchard · 1977 · Cancer
  41. Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X‐irradiation and glucocorticoids
    T. A. S. Amos, J. L. Lewis, F. H. Grand, Roger P. Gooding, John M. Goldman, M. Y. Gordon · 1995 · British Journal of Haematology
  42. Direct Binding of CRKL to BCR-ABL Is Not Required for BCR-ABL Transformation
    Conor Heaney, Kathryn S. Kolibaba, Arun Bhat, Tsukasa Oda, Sayuri Ohno-Jones, Shane Fanning, Brian J. Druker · 1997 · Blood
  43. Imatinib Mesylate
    Cornelius Florian Waller · 2018 · Recent results in cancer research/Recent Results in Cancer Research
  44. Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Jae‐Yong Kwak, Sung‐Hyun Kim, Suk Joong Oh, Dae Young Zang, Hawk Kim, Jeong‐A Kim, Young Rok Do, Hyeoung Joon Kim, Joon Seong Park, Chul Won Choi et al. · 2017 · Clinical Cancer Research
  45. The role of interferon-alpha in the treatment of chronic myeloid leukemia
    Lisa A. Kujawski, Moshe Talpaz · 2007 · Cytokine & Growth Factor Reviews
  46. Chronic Myeloid Leukemia
    Neil P. Shah, Charles L. Sawyers · 2003 · Humana Press eBooks
  47. Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia
    Signer, Robert A. J., Montecino-Rodriguez, Encarnacion, Witte, Owen N., McLaughlin, Jami, Dorshkind, Kenneth · 2007 · Blood
  48. Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia
    Stefan Balabanov, Melanie Braig, Tim H. Brümmendorf · 2014 · Drug Discovery Today Technologies
  49. Applications of Microfluidics in Stem Cell Biology
    Qiucen Zhang, Robert H. Austin · 2012 · BioNanoScience
  50. On the genesis and prognosis of variant translocations in chronic myeloid leukemia
    Madhavi Gorusu, PETER A. BENN, Zihai Li, Min Fang · 2007 · Cancer Genetics and Cytogenetics
  51. The Role of Mitotic Recombination in Carcinogenesis
    Christian Sengstag · 1994 · Critical Reviews in Toxicology
  52. Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes
    Partow Kebriaei, Rima M. Saliba, Gabriela Rondón, Alexandre Chiattone, Rajyalakshmi Luthra, Paolo N. Anderlini, Börje S. Andersson, Elizabeth J. Shpall, Uday Popat, Roy B. Jones et al. · 2011 · Transplantation and Cellular Therapy
  53. An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians
    Austin T. Granatowicz, Caroline Irene Piatek, Elizabeth Moschiano, Ihab El‐Hemaidi, Joel D. Armitage, Mojtaba Akhtari · 2015 · Korean Journal of Family Medicine
  54. The chromosomes and causation of human cancer and leukemia.XVIII. The missing γ in acute myeloblastic leukemia (aml) and Ph1-positive chronic myelocytic leukemia (CML)
    Masaharu Sakurai, Avery A. Sandberg · 1976 · Cancer
  55. Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL–expressing cells, demonstrating synergy between AG490 and STI571
    Xuemei Sun, Judith E. Layton, Andrew G. Elefanty, Graham John Lieschke · 2001 · Blood
  56. Bone Marrow Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    M. Stockshläder, Susanne Hegewisch-Becker, William Krüger, A. Tom Dieck, M. Hoffknecht, C. Berger, Brigitte Kohlschütter, Hans Martin, S Peters, H. Kabisch et al. · 1997 · Hämatologie und Bluttransfusion
  57. Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus.
    Genoveffa Franchini, Flossie Wong‐Staal, Marcel A. Baluda, Carole R. Lengel, Steven R. Tronick · 1983 · Proceedings of the National Academy of Sciences
  58. Chromosomes and causation of human cancer and leukemia. XLV. Chromosome patterns in stimulated lymphocytes of chronic lymphocytic leukemia
    Masuji Morita, Jun Minowada, A.A. Sandberg · 1981 · Cancer Genetics and Cytogenetics
  59. A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease
    Gillian Abigail Horne, Jon Stobo, Caroline Kelly, A. Mukhopadhyay, A. L. Latif, Judith Dixon-Hughes, Lynn McMahon, Pascale Cony‐Makhoul, Jenny Byrne, Graeme Smith et al. · 2020 · Leukemia
  60. Chronic Myelogenous Leukemia,BCR-ABL1+
    James W. Vardiman · 2009 · American Journal of Clinical Pathology
  61. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl
    Pierre Laneuville, G Sun, M Timm, Michel J. J. Vekemans · 1992 · Blood
  62. Editorial: The role of cytogenetics in hematology
    JD Rowley · 1976 · Blood
  63. The spectrum of adaptive mutations in experimental evolution
    Gregory I. Lang, Michael M. Desai · 2014 · Genomics
  64. Chromosomal rearrangements in cancer
    Paul Hasty, Cristina Montagna · 2014 · Molecular & Cellular Oncology
  65. Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Simona Soverini, Caterina D. Benedittis, Manuela Mancini, Giovanni Martinelli · 2015 · Clinical Lymphoma Myeloma & Leukemia
  66. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.
    E.F.M. Posthuma, J.H. Frederik Falkenburg, Jane F. Apperley, Alois A. Gratwohl, Eddy E. Roosnek, Bernd Hertenstein, Ronald F. Schipper, G. M. T. Schreuder, Joseph D'Amaro, Machteld Oudshoorn et al. · 1999 · PubMed
  67. STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia
    Michael E O'Dwyer, Brian J. Druker · 2000 · The Lancet Oncology
  68. T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study
    Sabrina Pricl, Maurizio Fermeglia, Marco L. Ferrone, Elena Tamborini · 2005 · Molecular Cancer Therapeutics
  69. Translating Genomics for Precision Cancer Medicine
    Sameek Roychowdhury, Arul M. Chinnaiyan · 2014 · Annual Review of Genomics and Human Genetics
  70. Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
    Hyewon Lee, Igor Novitzky‐Basso, Dennis Dong Hwan Kim · 2021 · International Journal of Hematology
  71. Computational immunogenomic approaches to predict response to cancer immunotherapies
    Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, Bruce W.S. Robinson, Jenette Creaney, Nicola Waddell · 2023 · Nature Reviews Clinical Oncology
  72. Targeting survival pathways in chronic myeloid leukaemia stem cells
    Anne E. Sinclair, A L Latif, Tessa L. Holyoake · 2013 · British Journal of Pharmacology
  73. Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
    Silvia Schenone, Chiara Brullo, Olga Bruno, Francesco Bondavalli, Luisa Mosti, Giovanni Maga, Emmanuele Crespan, Fabio Carraro, Fabrizio Manetti, Cristina Tintori et al. · 2008 · European Journal of Medicinal Chemistry
  74. The role of cytokines in immunological tolerance: potential for therapy
    Nicole E. McNeil, Thomas Ried · 2000 · Expert Reviews in Molecular Medicine
  75. Oncogenic mechanisms in myeloproliferative disorders
    François Delhommeau, Didier F. Pisani, Chloé James, Nicole Casadevall, Stefan N. Constantinescu, William Vainchenker · 2006 · Cellular and Molecular Life Sciences
  76. The Leukemias: A Half-Century of Discovery
    Emil J. Freireich, Peter H. Wiernik, David P. Steensma · 2014 · Journal of Clinical Oncology
  77. Functional Classification of Protein Kinase Binding Sites Using Cavbase
    Daniel Kühn, Nils Weskamp, Eyke Hüllermeier, Gerhard Klebe · 2007 · ChemMedChem
  78. Bionimbus: a cloud for managing, analyzing and sharing large genomics datasets
    Allison P. Heath, Matthew J. Greenway, Ray Powell, Jonathan Spring, Rafael D. Suarez, David Hanley, Chai Bandlamudi, Megan E. McNerney, Kevin P. White, Robert L. Grossman · 2014 · Journal of the American Medical Informatics Association
  79. Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment
    Ghayas C. Issa, Hagop M. Kantarjian, Graciela Nogueras González, Gautam M. Borthakur, Guilin Tang, William G. Wierda, Koji Sasaki, Nicholas James Short, Farhad Ravandi, Tapan Mahendra Kadia et al. · 2017 · Blood
  80. Molecular analysis of both translocation products of a Philadelphia-positive CML patient
    Annelies de Klein, Ton van Agthoven, Cora Groffen, Nora Heisterkamp, John Groffen, Gerard C. Grosveld · 1986 · Nucleic Acids Research
  81. Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells
    Pu Liu, Jeanette Siciliano, David Seong, Janet Craig, Ying Zhao, Pieter J. de Jong, Michael J. Siciliano · 1993 · Cancer Genetics and Cytogenetics
  82. The Cytogenetics of Chronic Granulocytic Leukaemia
    Sylvia D. Lawler · 1977 · Clinics in Haematology
  83. Commonality but Diversity in Cancer Gene Fusions
    Rabbitts, Terence H. · 2009 · Cell
  84. FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosis
    Zainab Jagani, Amrik J. Singh, Roya Khosravi‐Far · 2007 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  85. Biological Effects of Electromagnetic Fields and Recently Updated Safety Guidelines for Strong Static Magnetic Fields
    Sachiko Yamaguchi‐Sekino, Masaki Sekino, Shoogo Ueno · 2011 · Magnetic Resonance in Medical Sciences
  86. Modeling Philadelphia chromosome positive leukemias
    Stephane Wong, Owen N. Witte · 2001 · Oncogene
  87. Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma
    Martha I. Pedersen, Joan Wennstrom Bennett, Nancy Wang · 1986 · Cancer Genetics and Cytogenetics
  88. Preferential involvement of chromosomes no. 8 and no. 21 in acute leukemia and preleukemia
    K Yamada, S Furusawa · 1976 · Blood
  89. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes
    Fabio Stagno, Stefania Stella, Antonio Spitaleri, Maria Stella Pennisi, Francesco Di Raimondo, Paolo Giovanni Vigneri · 2016 · Expert Review of Anticancer Therapy
  90. The molecular mechanics of mixed lineage leukemia
    Robert K. Slany · 2016 · Oncogene
  91. Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor
    Xianbin Tian, Hefei Zhang, Tycho Heimbach, Handan He, Aby Buchbinder, Mary Aghoghovbia, Florence Hourcade‐Potelleret · 2018 · The Journal of Clinical Pharmacology
  92. Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes
    Raghvendra Vishwakarma, Kirk James McManus · 2020 · Cancers
  93. Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations
    Stephane Wong, Jami McLaughlin, Donghui Cheng, C. Zhang, Kevan M. Shokat, Owen N. Witte · 2004 · Proceedings of the National Academy of Sciences
  94. Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients
    Floor Weerkamp, Elisabeth H. A. Spaeny-Dekking, Yuk Yin Ng, Vincent H. J. van der Velden, Hobert Wai, Sebastian Böttcher, Monika Brüggemann, A J van der Sluijs, Alice J. Koning, Nancy Boeckx et al. · 2009 · Leukemia
  95. Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells
    Xingxiang Peng, Amit Kumar Tiwari, Hsiang-Chun Wu, Zhe‐Sheng Chen · 2011 · 癌症：英文版
  96. Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history
    Elias Joseph Jabbour, Andreas Hochhaus, Jörge E. Cortes, Paul Graf La Rosée, Hagop M. Kantarjian · 2009 · Leukemia
  97. Mechanisms of Transformation by the BCR/ABL Oncogene
    Martin Sattler, James D. Griffin · 2001 · International Journal of Hematology
  98. A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: Possible involvement in the genesis of the Philadelphia chromosome translocation
    Giuseppe Nicola Saglio, Clelia Tiziana Storlazzi, Emilia Giugliano, Cecilia Surace, Luisa Anelli, Giovanna Rege‐Cambrin, Antonella Zagaria, Antonio Jiménez‐Velasco, Anabel Heiniger, Patrizia Scaravaglio et al. · 2002 · Proceedings of the National Academy of Sciences
  99. Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome
    Masaki Warashina, Tomoko Kuwabara, Yuka Nakamatsu, Kazunari Taira · 1999 · Chemistry & Biology
  100. Human chronic lymphocytic leukemia: Karyotypes in different lymphocyte populations
    Kirsi Autio, Olli Turunen, Olli Penttilä, Eino Erämaa, Albert de la Chapelle, Jim Schröder · 1979 · Cancer Genetics and Cytogenetics